CRBU vs GRMN · rev $3.9M vs P/E 28, rev $7.25B
Caribou Biosciences Inc (CRBU) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
CRBU currently screens at market cap $190.4M. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the CRBU and GRMN stock pages for the full models.
Not investment advice.